DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
|You are receiving this because you have an account on www.oneGRAVESvoice.com|
|To unsubscribe from these emails, click here|
Trusted Resources: News & Meetings
Latest announcements and gatherings
Join Thyroid Federation International Webinar: Graves’ Disease and Thyroid Eye Disease on May 25, 2022, 2:00 PM CET with Nancy Hord Patterson, Founder and Chair Emeritus of Graves’ Disease and Thyroid Foundation.
This event has ended.
News & MeetingsAsk the Docs Webinar – GDATFJoin us for a webinar hosted by the Grav...
News & MeetingsGDATF Webinar: Long-Term Use of Antithyroid DrugsThe Graves’ Disease and Thyroid Founda...
Videos & VisualsCoronavirus Preparedness for People with Chronic Diseaseshttps://www.youtube.com/watch?v=G_JC3vUT...
Videos & VisualsBlack & Rare: Thyroid Eye Disease Webinarhttps://www.youtube.com/watch?v=lzkSVY4E...
Videos & VisualsLiving Well With Thyroid Eye Disease – Webinarhttps://www.youtube.com/watch?v=45_mIC7b...
News & MeetingsLiving With Thyroid Eye Disease – WebinarJoin the Alliance for Patient Access...
Videos & VisualsAsk the Docs Webinar – GDATFhttps://www.youtube.com/watch?v=Uqj_wYtx...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.